ClinicalTrials.Veeva

Menu

Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia. (TherMO)

C

Centre Hospitalier Universitaire de Besancon

Status and phase

Completed
Phase 2
Phase 1

Conditions

Lung Tumor
Bone Tumor
Renal Tumor

Treatments

Device: Microwave ablation with Acculis Accu2i pMTA Applicator

Study type

Interventional

Funder types

Other

Identifiers

NCT02862288
API/2011/23

Details and patient eligibility

About

The aims of this work were to assess the feasibility, efficacy, short-term outcome and safety of microwave ablation in the treatment of malignant bone, lung and renal tumors.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men and women > 18 years old
  • Thermoablation indication of renal neoplasia, bone or lung decided during a multidisciplinary consultation meeting - Generally speaking, the indications are: (i) inoperable primary malignant tumor or secondary malignant tumor, (ii) resectable primary malignant renal and lung tumor with medical contraindication to surgery or general anesthesia
  • Signature of informed consent for participation
  • Affiliation to a social security scheme or French beneficiary of such a regime.

Exclusion criteria

  • Contraindication to percutaneous thermoablation
  • Renal or lung tumor up to 4 cm
  • Women of childbearing age, premenopausal, non-sterilized surgically, and unwilling to use effective contraception
  • Legal incapacity or legal capacity limited
  • Person unlikely to cooperate in the study and / or low degree of cooperation expected by the investigator
  • Person without health insurance
  • Pregnant women

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

30 participants in 3 patient groups

Renal tumor
Experimental group
Description:
Microwave ablation of renal tumor
Treatment:
Device: Microwave ablation with Acculis Accu2i pMTA Applicator
Lung tumor
Experimental group
Description:
Microwave ablation of lung tumor
Treatment:
Device: Microwave ablation with Acculis Accu2i pMTA Applicator
Bone tumor
Experimental group
Description:
Microwave ablation of bone tumor
Treatment:
Device: Microwave ablation with Acculis Accu2i pMTA Applicator

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems